Trans-nasal Complete Nasolabial Cyst Excision

Completed

• Conditions: Nasolabial Cyst

• Registration Number: NCT05532462
• Lead Sponsor: Sohag University

Brief Summary

Background: Nasolabial cysts are rare benign epithelial nonodontogenic soft tissue cysts arising in the nasal alar region. Sublabial excision or transnasal endoscopic marsupialization is the standard treatment.

Patients and methods: Between 2019 and 2022, a descriptive retrospective study, including 20 patients who presented with Nasolabial cysts, was conducted.

Detailed Description

A retrospective study of patients who were presented in the period from 2019 to 2022, with nasolabial cysts. Patients' files were checked for demographic data, clinical presentation, preoperative radiological investigations, histopathology, surgical approach, complications, and outcome.

Technique:

The surgery is carried out mainly using x5 magnification loupe and 0° degree sinoscope. Submucosal infiltration (lidocaine 2% and 1:100,000 adrenaline). An incision was made at the mucosal covering of the cyst wall and nasal floor in a transverse and anteroposterior direction. The mucosal flap is elevated and separated from the cyst wall and reflected toward the septum side. During dissection, cyst content is usually drained. The whole cyst wall was carefully dissected with sharp and blunt dissection from the mucous membrane, and laterally from the premaxillary area. Finally, endoscopic examination to check the operative bed and refashioning mucosal flap coverage. If mucosal flap is lacerated, then excised and operative bed left for healing by creeping from surrounding edges. Endoscopic trans-nasal complete excision has a shorter operative time, minimal intraoperative bleeding, and no postoperative pain or edema reported.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2022-03-25
• Primary Completion: 2022-05-22
• Study Completion: 2022-07-05
• Study First Submitted: 2022-08-24
• Status Verified: 2022-09
• Study First Submitted QC: 2022-09-04
• Last Update Submitted: 2022-09-04
• Study First Posted: 2022-09-08
• Last Update Posted: 2022-09-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

•Nasolabial cyst

Read More

Exclusion Criteria

• Recurrent cases
• Previous operated

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms and clinical sign	2 years	The presenting symptoms which made the patient sought medical advice
Preoperative Computer tomography or soft tissue ultrasound	2 years	Radiological description of the lesion
lining epithelium and inflammatory cell in wall of histopathology	2 years	histopathological criteria of the epithelium and cyst wall
complications and outcome	2 years	postoperative complication or recurrence

Trial Locations

Locations (1)

Mohammed Elrabie Ahmed; 🇪🇬 Sohag, Egypt